Fonseca, P. J., Uriol, E., Galván, J. A., Álvarez, C., Pérez, Q., Villanueva, N., . . . Viéitez, J. M. (2013). Prolonged Clinical Benefit of Everolimus Therapy in the Management of High-Grade Pancreatic Neuroendocrine Carcinoma. S. Karger AG.
Chicago Style CitationFonseca, Paula J., Esther Uriol, José A. Galván, Carlos Álvarez, Quionia Pérez, Noemi Villanueva, José P. Berros, Marta Izquierdo, and José M. Viéitez. Prolonged Clinical Benefit of Everolimus Therapy in the Management of High-Grade Pancreatic Neuroendocrine Carcinoma. S. Karger AG, 2013.
MLA CitationFonseca, Paula J., et al. Prolonged Clinical Benefit of Everolimus Therapy in the Management of High-Grade Pancreatic Neuroendocrine Carcinoma. S. Karger AG, 2013.
Warning: These citations may not always be 100% accurate.